Neuroendocrine tumors originate from neuroendocrine cells, often presenting as slower-growing compared to other cancers like ...

The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

The EMERALD study carries significant implications across multiple stakeholders in ER+/HER2- metastatic breast cancer. For ...

The lidERA Breast Cancer study is a phase 3, randomized, open-label trial testing whether the adjuvant therapy giredestrant ...

The endocrine system plays a crucial role in regulating physiological processes and maintaining homeostasis. While previous ...

Endocrine-disrupting chemicals (EDCs) are a class of chemicals that mimic, block or interfere with the production, metabolism or action of hormones in the body. As EDCs are ubiquitous in our ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Numerous companies offer tests, which may involve blood, urine or saliva collection, and can be very expensive. The results ...

The endocrine system is the name for the glands that produce hormones in a person’s body. These glands include the thyroid gland, pituitary gland, and adrenal gland. The endocrine system produces ...

Endocrine therapy is a way of treating conditions such as cancer using hormones. Also known as hormone therapy, it involves adjusting the levels of certain hormones, such as testosterone, estrogen, ...

Thyroid cancer is often a highly treatable disease. Most cases are detected in early stages and have excellent outcomes.